AustralieFrV1, PubMed, Corpus, bibRecord, 001B75

Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma.

Identifieur interne : 001B75 ( PubMed/Corpus ); précédent : 001B74; suivant : 001B76

Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma.

Auteurs : Barbara Pro ; Steven M. Horwitz ; H Miles Prince ; Francine M. Foss ; Lubomir Sokol ; Matthew Greenwood ; Dolores Caballero ; Franck Morschhauser ; Martin Wilhelm ; Swaminathan Padmanabhan Iyer ; Andrei R. Shustov ; Julie Wolfson ; Barbara E. Balser ; Bertrand Coiffier

Source :

Hematological oncology [ 1099-1069 ] ; 2016.

RBID : pubmed:27402335
DOI: 10.1002/hon.2320
PubMed: 27402335

Links to Exploration step

pubmed:27402335

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma.</title>
<author><name sortKey="Pro, Barbara" sort="Pro, Barbara" uniqKey="Pro B" first="Barbara" last="Pro">Barbara Pro</name>
<affiliation><nlm:affiliation>Robert H. Laurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Horwitz, Steven M" sort="Horwitz, Steven M" uniqKey="Horwitz S" first="Steven M" last="Horwitz">Steven M. Horwitz</name>
<affiliation><nlm:affiliation>Lymphoma Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Prince, H Miles" sort="Prince, H Miles" uniqKey="Prince H" first="H Miles" last="Prince">H Miles Prince</name>
<affiliation><nlm:affiliation>Center for Blood Cell Therapies, Peter MacCallum Cancer Center, Melbourne, VIC, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Foss, Francine M" sort="Foss, Francine M" uniqKey="Foss F" first="Francine M" last="Foss">Francine M. Foss</name>
<affiliation><nlm:affiliation>Yale Cancer Center, Yale Medical Group, New Haven, CT, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sokol, Lubomir" sort="Sokol, Lubomir" uniqKey="Sokol L" first="Lubomir" last="Sokol">Lubomir Sokol</name>
<affiliation><nlm:affiliation>Malignant Hematology, Moffitt Cancer Center & Research Institute, Tampa, FL, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Greenwood, Matthew" sort="Greenwood, Matthew" uniqKey="Greenwood M" first="Matthew" last="Greenwood">Matthew Greenwood</name>
<affiliation><nlm:affiliation>Department of Hematology, Royal North Shore Hospital, St Leonards, NSW, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Caballero, Dolores" sort="Caballero, Dolores" uniqKey="Caballero D" first="Dolores" last="Caballero">Dolores Caballero</name>
<affiliation><nlm:affiliation>Hospital Universitario de Salamanca, Salamanca, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Morschhauser, Franck" sort="Morschhauser, Franck" uniqKey="Morschhauser F" first="Franck" last="Morschhauser">Franck Morschhauser</name>
<affiliation><nlm:affiliation>Hematology, Centre Hospitalier Régional Universitaire de Lille, Lille, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wilhelm, Martin" sort="Wilhelm, Martin" uniqKey="Wilhelm M" first="Martin" last="Wilhelm">Martin Wilhelm</name>
<affiliation><nlm:affiliation>Paracelsus Medical University, Klinikum Nuernberg, Nuernberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Iyer, Swaminathan Padmanabhan" sort="Iyer, Swaminathan Padmanabhan" uniqKey="Iyer S" first="Swaminathan Padmanabhan" last="Iyer">Swaminathan Padmanabhan Iyer</name>
<affiliation><nlm:affiliation>Houston Methodist Cancer Center, Houston, TX, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Shustov, Andrei R" sort="Shustov, Andrei R" uniqKey="Shustov A" first="Andrei R" last="Shustov">Andrei R. Shustov</name>
<affiliation><nlm:affiliation>Clinical Research Division, University of Washington, Seattle, WA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wolfson, Julie" sort="Wolfson, Julie" uniqKey="Wolfson J" first="Julie" last="Wolfson">Julie Wolfson</name>
<affiliation><nlm:affiliation>Veristat, LLC, Southborough, MA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Balser, Barbara E" sort="Balser, Barbara E" uniqKey="Balser B" first="Barbara E" last="Balser">Barbara E. Balser</name>
<affiliation><nlm:affiliation>Veristat, LLC, Southborough, MA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Coiffier, Bertrand" sort="Coiffier, Bertrand" uniqKey="Coiffier B" first="Bertrand" last="Coiffier">Bertrand Coiffier</name>
<affiliation><nlm:affiliation>Hospices Civils de Lyon, University of Lyon, Pierre-Benite, France.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27402335</idno>
<idno type="pmid">27402335</idno>
<idno type="doi">10.1002/hon.2320</idno>
<idno type="wicri:Area/PubMed/Corpus">001B75</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001B75</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma.</title>
<author><name sortKey="Pro, Barbara" sort="Pro, Barbara" uniqKey="Pro B" first="Barbara" last="Pro">Barbara Pro</name>
<affiliation><nlm:affiliation>Robert H. Laurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Horwitz, Steven M" sort="Horwitz, Steven M" uniqKey="Horwitz S" first="Steven M" last="Horwitz">Steven M. Horwitz</name>
<affiliation><nlm:affiliation>Lymphoma Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Prince, H Miles" sort="Prince, H Miles" uniqKey="Prince H" first="H Miles" last="Prince">H Miles Prince</name>
<affiliation><nlm:affiliation>Center for Blood Cell Therapies, Peter MacCallum Cancer Center, Melbourne, VIC, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Foss, Francine M" sort="Foss, Francine M" uniqKey="Foss F" first="Francine M" last="Foss">Francine M. Foss</name>
<affiliation><nlm:affiliation>Yale Cancer Center, Yale Medical Group, New Haven, CT, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sokol, Lubomir" sort="Sokol, Lubomir" uniqKey="Sokol L" first="Lubomir" last="Sokol">Lubomir Sokol</name>
<affiliation><nlm:affiliation>Malignant Hematology, Moffitt Cancer Center & Research Institute, Tampa, FL, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Greenwood, Matthew" sort="Greenwood, Matthew" uniqKey="Greenwood M" first="Matthew" last="Greenwood">Matthew Greenwood</name>
<affiliation><nlm:affiliation>Department of Hematology, Royal North Shore Hospital, St Leonards, NSW, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Caballero, Dolores" sort="Caballero, Dolores" uniqKey="Caballero D" first="Dolores" last="Caballero">Dolores Caballero</name>
<affiliation><nlm:affiliation>Hospital Universitario de Salamanca, Salamanca, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Morschhauser, Franck" sort="Morschhauser, Franck" uniqKey="Morschhauser F" first="Franck" last="Morschhauser">Franck Morschhauser</name>
<affiliation><nlm:affiliation>Hematology, Centre Hospitalier Régional Universitaire de Lille, Lille, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wilhelm, Martin" sort="Wilhelm, Martin" uniqKey="Wilhelm M" first="Martin" last="Wilhelm">Martin Wilhelm</name>
<affiliation><nlm:affiliation>Paracelsus Medical University, Klinikum Nuernberg, Nuernberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Iyer, Swaminathan Padmanabhan" sort="Iyer, Swaminathan Padmanabhan" uniqKey="Iyer S" first="Swaminathan Padmanabhan" last="Iyer">Swaminathan Padmanabhan Iyer</name>
<affiliation><nlm:affiliation>Houston Methodist Cancer Center, Houston, TX, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Shustov, Andrei R" sort="Shustov, Andrei R" uniqKey="Shustov A" first="Andrei R" last="Shustov">Andrei R. Shustov</name>
<affiliation><nlm:affiliation>Clinical Research Division, University of Washington, Seattle, WA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wolfson, Julie" sort="Wolfson, Julie" uniqKey="Wolfson J" first="Julie" last="Wolfson">Julie Wolfson</name>
<affiliation><nlm:affiliation>Veristat, LLC, Southborough, MA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Balser, Barbara E" sort="Balser, Barbara E" uniqKey="Balser B" first="Barbara E" last="Balser">Barbara E. Balser</name>
<affiliation><nlm:affiliation>Veristat, LLC, Southborough, MA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Coiffier, Bertrand" sort="Coiffier, Bertrand" uniqKey="Coiffier B" first="Bertrand" last="Coiffier">Bertrand Coiffier</name>
<affiliation><nlm:affiliation>Hospices Civils de Lyon, University of Lyon, Pierre-Benite, France.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Hematological oncology</title>
<idno type="eISSN">1099-1069</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">27402335</PMID>
<DateCreated><Year>2016</Year>
<Month>08</Month>
<Day>19</Day>
</DateCreated>
<DateRevised><Year>2017</Year>
<Month>09</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-1069</ISSN>
<JournalIssue CitedMedium="Internet"><PubDate><Year>2016</Year>
<Month>Jul</Month>
<Day>12</Day>
</PubDate>
</JournalIssue>
<Title>Hematological oncology</Title>
<ISOAbbreviation>Hematol Oncol</ISOAbbreviation>
</Journal>
<ArticleTitle>Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma.</ArticleTitle>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/hon.2320</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pro</LastName>
<ForeName>Barbara</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>Robert H. Laurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Horwitz</LastName>
<ForeName>Steven M</ForeName>
<Initials>SM</Initials>
<AffiliationInfo><Affiliation>Lymphoma Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Prince</LastName>
<ForeName>H Miles</ForeName>
<Initials>HM</Initials>
<AffiliationInfo><Affiliation>Center for Blood Cell Therapies, Peter MacCallum Cancer Center, Melbourne, VIC, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Foss</LastName>
<ForeName>Francine M</ForeName>
<Initials>FM</Initials>
<AffiliationInfo><Affiliation>Yale Cancer Center, Yale Medical Group, New Haven, CT, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sokol</LastName>
<ForeName>Lubomir</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Malignant Hematology, Moffitt Cancer Center & Research Institute, Tampa, FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Greenwood</LastName>
<ForeName>Matthew</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Hematology, Royal North Shore Hospital, St Leonards, NSW, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Caballero</LastName>
<ForeName>Dolores</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Hospital Universitario de Salamanca, Salamanca, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Morschhauser</LastName>
<ForeName>Franck</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Hematology, Centre Hospitalier Régional Universitaire de Lille, Lille, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wilhelm</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Paracelsus Medical University, Klinikum Nuernberg, Nuernberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Iyer</LastName>
<ForeName>Swaminathan Padmanabhan</ForeName>
<Initials>SP</Initials>
<AffiliationInfo><Affiliation>Houston Methodist Cancer Center, Houston, TX, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Shustov</LastName>
<ForeName>Andrei R</ForeName>
<Initials>AR</Initials>
<AffiliationInfo><Affiliation>Clinical Research Division, University of Washington, Seattle, WA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wolfson</LastName>
<ForeName>Julie</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Veristat, LLC, Southborough, MA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Balser</LastName>
<ForeName>Barbara E</ForeName>
<Initials>BE</Initials>
<AffiliationInfo><Affiliation>Veristat, LLC, Southborough, MA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Coiffier</LastName>
<ForeName>Bertrand</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>Hospices Civils de Lyon, University of Lyon, Pierre-Benite, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2016</Year>
<Month>07</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Hematol Oncol</MedlineTA>
<NlmUniqueID>8307268</NlmUniqueID>
<ISSNLinking>0278-0232</ISSNLinking>
</MedlineJournalInfo>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year>
<Month>04</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2016</Year>
<Month>05</Month>
<Day>23</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2016</Year>
<Month>05</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>7</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>7</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>7</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">27402335</ArticleId>
<ArticleId IdType="doi">10.1002/hon.2320</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B75 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001B75 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:27402335
   |texte=   Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:27402335" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma.

Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma.

Source :

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki